Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial

  1. Lingvay, I.
  2. Harris, S.
  3. Jaeckel, E.
  4. Chandarana, K.
  5. Ranthe, M.F.
  6. Jódar, E.
Aldizkaria:
Diabetes, Obesity and Metabolism

ISSN: 1463-1326,  1462-8902

Argitalpen urtea: 2018

Alea: 20

Zenbakia: 1

Orrialdeak: 200-205

Mota: Artikulua

DOI: 10.1111/DOM.13043 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus